Literature DB >> 7013687

Disorders of glutamate metabolism and neurological dysfunction.

S B Prusiner.   

Abstract

Disorders of glutamate metabolism are associated with profound alteration of CNS function. Although the precise biochemical mechanisms responsible for nervous system dysfunction in most of these disorders are unknown, it can be concluded that biochemical aberrations in the metabolism of glutamate usually result in malfunction of the CNS. As with most disorders of amino acid metabolism that are associated with brain dysfunction, the molecular mechanisms underlying pathogenesis of these disorders remain obscure. Why do some biochemically affected individuals remain free of significant neurological involvement? The explanation that the accumulation of a specific metabolite is responsible for the pathogenesis of a disease process does not answer this and may frequently prove to be incorrect. More complete descriptions of these disorders of glutamate metabolism and their attendant neurological dysfunction will be required before any firm linkage between the biochemical defects and the clinical manifestations of the disease processes can be established. In addition, a much greater knowledge of the control mechanisms regulating glutamate metabolism in the CNS will be needed before the complexities of these disorders can be fully understood. Finally, the dual role of glutamate metabolites as intermediates in crucial pathways of metabolism and as neurotransmitters modulating electrical signals stresses the complexity and importance of glutamate metabolism in CNS function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7013687     DOI: 10.1146/annurev.me.32.020181.002513

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  8 in total

1.  Microarray analysis of sexually dimorphic gene expression in human minor salivary glands.

Authors:  D Michael; S Soi; J Cabera-Perez; M Weller; S Alexander; I Alevizos; Gg Illei; Ja Chiorini
Journal:  Oral Dis       Date:  2011-08-08       Impact factor: 3.511

2.  Genetic control of platelet glutaminase: a twin study.

Authors:  S Sahai; F Vogel
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

Review 3.  Glutamate in the mammalian CNS.

Authors:  S Sahai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

4.  Comparisons of mass spectrometry compatible surfactants for global analysis of the mammalian brain proteome.

Authors:  Emily I Chen; Daniel McClatchy; Sung Kyu Park; John R Yates
Journal:  Anal Chem       Date:  2008-10-21       Impact factor: 6.986

5.  Critical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region.

Authors:  Susana Isabel Ferreira; Eunice Matoso; Margarida Venâncio; Jorge Saraiva; Joana B Melo; Isabel Marques Carreira
Journal:  Mol Cytogenet       Date:  2012-05-02       Impact factor: 2.009

6.  Delineation of 2q32q35 deletion phenotypes: two apparent "proximal" and "distal" syndromes.

Authors:  Adrian Mc Cormack; Juliet Taylor; Nerine Gregersen; Alice M George; Donald R Love
Journal:  Case Rep Genet       Date:  2013-06-09

7.  Integrative decomposition procedure and Kappa statistics for the distinguished single molecular network construction and analysis.

Authors:  Lin Wang; Ying Sun; Minghu Jiang; Xiguang Zheng
Journal:  J Biomed Biotechnol       Date:  2009-04-14

8.  Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6 Mb deletion of 2q32.2q33.1.

Authors:  Hojka Gregoric Kumperscak; Danijela Krgovic; Nadja Kokalj Vokac
Journal:  J Int Med Res       Date:  2016-01-25       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.